Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)
Close on Nov 13, 2026Market cap $5.33MP/E –Yield –
Intelligent Bio Solutions statistics
77 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.07
- 4.81
Enterprise valuationIndustry
- EV / Sales
- -0.19
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 214.9%
- 3.32%
- Shares Change (QoQ)
- 14.2%
- 0.20%
- Float
- 3M
- 37M
- Shares Held by Insiders
- 2.99%
- 10.5%
- Shares Held by Institutions
- 5.99%
- 60.5%
Short sellingIndustry
- Short Interest
- 63,545
- –
- Short Interest Change
- -30.3%
- -2.57%
- Short % of Float
- 2.16%
- 5.11%
- Short % of Shares Outstanding
- 2.10%
- 3.98%
- Days to Cover
- 3.08
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $24.90
- –
- 52-Week Low
- $1.35
- –
- 20-Day Moving Average
- $1.80
- –
- 50-Day Moving Average
- $1.79
- –
- 200-Day Moving Average
- $2.73
- –
- Average True Range (14)
- $0.17
- –
- Price Change (1 Week)
- -10.7%
- 0.99%
- Price Change (1 Month)
- 22.2%
- -3.52%
- Price Change (3 Months)
- -47.8%
- -7.86%
- Price Change (6 Months)
- -56.1%
- -1.12%
- Price Change (YTD)
- -81.5%
- -2.92%
- Price Change (1 Year)
- -77.8%
- -1.37%
- Price Change (3 Years)
- -97.4%
- 3.24%
- Price Change (5 Years)
- -100.0%
- -50.4%
- Average Volume (10 Days)
- 56,867
- –
- Average Volume (20 Days)
- 38,682
- –
- Average Volume (90 Days)
- 127,960
- –
- Relative Volume
- 0.54
- 0.76
- Relative Strength Index (14)
- 47.4
- 46.7
- Volatility (1 Year)
- 178.6%
- 64.2%
- Beta (5 Years)
- 1.97
- 1.04
MarginsIndustry
- EBITDA Margin
- -246.5%
- -2.52%
Returns on capitalIndustry
- Return on Equity (ROE)
- -216.1%
- -17.3%
- Return on Assets (ROA)
- -102.3%
- -12.3%
- Return on Invested Capital (ROIC)
- -534.9%
- -2.83%
- Return on Capital Employed (ROCE)
- -135.3%
- -8.13%
Financial positionIndustry
- Current Ratio
- 1.98
- 2.49
- Quick Ratio
- 1.51
- 1.53
- Interest Coverage
- -187.68
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 36.5%
- 9.42%
- Revenue Growth (3Y CAGR)
- 49.7%
- 7.08%
- Revenue Growth (5Y CAGR)
- 16.3%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.38
- 0.59
- Inventory Turnover
- 3.99
- 2.20
- Revenue Per Employee
- $321.09K
- $331.99K
- Profits Per Employee
- -$864.73K
- -$46.47K
- Employee Count
- 14
- 193
- WACC
- 15.0%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $5.93M
- $3.95M
- Net Cash Per Share
- $1.96
- $0.26
- Equity (Book Value)
- $7.58M
- $63.80M
- Book Value Per Share
- $2.50
- $3.26
- Tangible Book Value
- $4.99M
- $11.61M
- Working Capital
- $4.47M
- $57.32M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -227.2%
- -4.76%
Taxes and interestIndustry
- Interest Expense
- $65.19K
- $5.40M
Scores and fair valueIndustry
- Altman Z-Score
- -9.71
- 2.47
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- -2.33
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | INBS | S&P 500 | Difference | INBS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.9% | -3.0% | +22.0 pts | ||
| 3 months | -41.3% | -2.8% | −38.6 pts | ||
| Year to date | -81.5% | +11.5% | −93.0 pts | ||
| 1 year | -75.4% | +13.5% | −88.9 pts | ||
| 3 years | -97.2% | +77.7% | −174.9 pts | -69.6% | +21.1% |
| 5 years | -100.0% | +72.6% | −172.6 pts | -79.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M INBS shares were sold short on Oct 30, 2026, down 30.3% from the previous report, or 2.16% of the shares available to trade. At recent volumes it would take 3.1 days to buy them back. Over the last 20 sessions, 46.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 63,545 | -30.3% | 20,658 | 3.1 |
| Oct 15, 2026 | 91,113 | +56.3% | 63,185 | 1.4 |
| Sep 30, 2026 | 58,294 | -51.2% | 41,999 | 1.4 |
| Sep 15, 2026 | 119,549 | +255.0% | 542,875 | 1.0 |
| Aug 31, 2026 | 33,673 | -68.0% | 90,645 | 1.0 |
| Aug 14, 2026 | 105,073 | +112.8% | 110,853 | 1.0 |
| Jul 31, 2026 | 49,375 | -52.2% | 101,425 | 1.0 |
| Jul 15, 2026 | 103,339 | +21.3% | 60,884 | 1.7 |
| Jun 30, 2026 | 85,165 | -19.9% | 37,292 | 2.3 |
| Jun 15, 2026 | 106,385 | +16.7% | 68,709 | 1.6 |
| May 29, 2026 | 91,169 | -38.8% | 110,774 | 1.0 |
| May 15, 2026 | 149,005 | +172.7% | 247,781 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?